Sami Ventelä
Turku Centre for Biotechnology satuve@utu.fi |
- Added value of HPV-DNA in situ hybridization as an adjunct to p16 Immunohistochemistry in oropharyngeal squamous cell carcinoma (2025)
- Acta Oto-Laryngologica
- Evaluation of Integrin Glycovariants as Biomarkers of Metastasis, Invasion, and Therapy Stratification in Head and Neck Squamous Cell Carcinoma (2025)
- Cancer Medicine
- Histological tumor necrosis predicts decreased survival after neoadjuvant chemotherapy in head and neck squamous cell carcinoma (2025)
- Oral Oncology
- Risk of early death after treatment with curative intent for head and neck squamous cell carcinoma: a retrospective population-based study (2025)
- Acta Oncologica
- Sinonasal adenoid cystic carcinomas accompanied by seromucinous hamartoma and/or atypical sinonasal glands arising from seromucinous hamartoma: insight into their histogenesis (2025)
- Virchows Archiv
- Assessment of targeted therapy opportunities in sinonasal cancers using patient-derived functional tumor models (2024)
- Translational Oncology
- Germline-specific RNA helicase DDX4 forms cytoplasmic granules in cancer cells and promotes tumor growth (2024)
- Cell Reports
- Identification of stemness-related glycosylation changes in head and neck squamous cell carcinoma (2024)
- BMC Cancer
- Multiparameter imaging reveals clinically relevant cancer cell-stroma interaction dynamics in head and neck cancer (2024)
- Cell
- xCT as a Predictor for Survival in a Population‐Based Cohort of Head and Neck Squamous Cell Carcinoma (2024)
- Cancer Medicine
- Prognostic histological markers in oral tongue squamous cell carcinoma patients treated with (chemo)radiotherapy (2023)
- APMIS
- Programmed death-ligand 1 and tumor-infiltrating lymphocytes (TILs) - low TIL density may predict poorer long-term prognosis in T1 laryngeal cancer (2023)
- Virchows Archiv
- The effect of matrices on the gene expression profile of patient-derived head and neck carcinoma cells for in vitro therapy testing (2023)
- Cancer Cell International
- TSPO is a potential independent prognostic factor associated with cellular respiration and p16 in head and neck squamous cell carcinoma (2023)
- Frontiers in Oncology
- Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma (2022)
- Oral Oncology
- Epidemiological Study of p16 Incidence in Head and Neck Squamous Cell Carcinoma 2005-2015 in a Representative Northern European Population (2022)
- Cancers
- Exposure to alcohol and overall survival in head and neck cancer: A regional cohort study (2022)
- Head and Neck
- Korvakäytävän punajäkälä - diagnoosiin varhain kuulon heikkenemisen estämiseksi (2022)
- Duodecim
- Cancer cell line microarray as a novel screening method for identification of radioresistance biomarkers in head and neck squamous cell carcinoma (2021)
- BMC Cancer
- Evaluation of prognostic biomarkers in a population-validated Finnish HNSCC patient cohort (2021)
- European Archives of Oto-Rhino-Laryngology